Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
1.900
+0.040 (2.15%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Advanced Biomed Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Selling, General & Admin
1.551.661.690.750.1
Research & Development
0.950.881.381.621.73
Operating Expenses
2.52.543.072.371.84
Operating Income
-2.5-2.54-3.07-2.37-1.84
Interest & Investment Income
0.050.050.0200
Currency Exchange Gain (Loss)
-0.56-0.29-0.51--
Other Non Operating Income (Expenses)
-0.030-0.02-0.04-0
EBT Excluding Unusual Items
-3.04-2.78-3.58-2.41-1.84
Impairment of Goodwill
----1.62-
Gain (Loss) on Sale of Assets
---0.15--
Pretax Income
-3.04-2.78-3.73-4.03-1.84
Net Income
-3.04-2.78-3.73-4.03-1.84
Net Income to Common
-3.04-2.78-3.73-4.03-1.84
Shares Outstanding (Basic)
2020201411
Shares Outstanding (Diluted)
2020201411
Shares Change (YoY)
0.11%0.32%40.55%23.74%-
EPS (Basic)
-0.15-0.14-0.19-0.28-0.16
EPS (Diluted)
-0.15-0.14-0.19-0.28-0.16
Free Cash Flow
-2.45-2.2-3.17-1.63-0.5
Free Cash Flow Per Share
-0.12-0.11-0.16-0.12-0.04
EBITDA
-2.19-2.27-2.84-2.26-1.78
D&A For EBITDA
0.310.270.230.110.06
EBIT
-2.5-2.54-3.07-2.37-1.84
Updated Jan 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q